2927 — AFC-HD AMS Life Science Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for AFC-HD AMS Life Science, fiscal year end - August 31st, JPY millions except per share, conversion factor applied.
2022 August 31st | 2023 August 31st | 2024 August 31st | 2025 August 31st | 2026 August 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Preliminary |
| Net Income/Starting Line | 1,235 | 1,546 | 1,911 | 2,201 | 1,969 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -238 | 102 | 80.9 | 344 | 643 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -512 | -1,767 | -1,537 | -2,156 | -2,408 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,492 | 865 | 1,540 | 1,787 | 1,678 |
| Capital Expenditures | -958 | -1,940 | -3,407 | -3,539 | -2,405 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -120 | -6.33 | 645 | 212 | -449 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,078 | -1,946 | -2,761 | -3,327 | -2,853 |
| Financing Cash Flow Items | -584 | -52.7 | -37.8 | 66.3 | 640 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,160 | 1,881 | 2,232 | 668 | -616 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1,591 | 804 | 1,009 | -871 | -1,770 |